Soft Tissue Allografts Market Size
| Study Period | 2019 - 2029 |
| Market Size (2024) | USD 3.70 Billion |
| Market Size (2029) | USD 5.12 Billion |
| CAGR (2024 - 2029) | 6.74 % |
| Fastest Growing Market | Asia Pacific |
| Largest Market | North America |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Need a report that reflects how COVID-19 has impacted this market and its growth?
Soft Tissue Allografts Market Analysis
The Soft Tissue Allografts Market size is estimated at USD 3.70 billion in 2024, and is expected to reach USD 5.12 billion by 2029, growing at a CAGR of 6.74% during the forecast period (2024-2029).
COVID-19 impacted the soft tissue allografts market in its initial phase owing to the cancellations of soft tissue repair procedures. For instance, according to an article published in the International Journal of Environmental Research and Public Health in March 2021, a study was conducted in Poland which showed that the pandemic has substantially impacted the number of dental procedures performed including dental repair procedures, in the initial phase of the pandemic. Furthermore, according to an article published in Cureus Journal in September 2022, a study was conducted in Scotland that stated the total number of hernia repair surgeries taking place in the country reduced considerably during the initial pandemic. The majority of this was due to the decrease in the number of elective operations, with the percentage of elective repair surgeries reducing significantly from 85.6% to 58.4%. However, the market recovered in the last two years since the restrictions were lifted and soft tissue allograft procedures resumed worldwide. The market is expected to register a stable growth rate during the forecast period.
According to the data published by the National Safety Council of the United States in 2021, an estimated 3.2 million people were treated in emergency departments for injuries involving sports and recreational equipment in the United States in 2021. The most common activities that were frequently associated with injuries were exercise, cycling, and basketball. The injury rate for exercise was 123.8 per 100,000 population in the United States in 2021, for bicycles and accessories it was 113.7, for basketball it was 78.6, for skateboards, scooters, and hoverboards it was 74.2, and for football, it was 67.2. Therefore, the large number of sports injuries leads to rising demand for soft tissue allografts in athletics and other sports, thereby contributing largely to the market growth.
Soft tissue allografts are used in spinal surgery and osteochondral defects during knee surgery. The high burden of such cases is expected to propel market growth. For instance, an article published in Médecine Intensive Réanimation in September 2021 stated that the number of spinal cord injuries is around 2000 new cases per year in France. Additionally, according to the French Road Safety Observatory (ONISR), 2023 update, there were 53.5 thousand injury traffic accidents and 67.0 thousand injured people during the accident in mainland France in 2021. The high burden of spinal cord injury and road accidents is anticipated to boost the demand for the use of allografts in orthopedic and spinal surgery, thereby propelling the market growth during the forecast period.
Furthermore, the strategic initiatives adopted by market players such as innovation in technology, product approvals & launches, along with partnerships to expand the soft tissue allografts offerings contribute significantly to the market growth. For instance, in October 2021, AlloSource launched AlloMend Extra-Large (XL) Acellular Dermal Matrix (ADM), a dermal graft that offers desired handling characteristics enabling precision placement. Also, in January 2021, Direct Biologics LLC launched AmnioWrap placental-based sheet allografts for clinical use. AmnioWrap is a unique, tri-layer graft intended for applications in acute and chronic wounds. The rising approvals and partnerships are expected to propel the market growth during the forecast period.
Therefore, owing to the aforementioned factors such as the high burden of sports and road accident injuries and rising product launches by market players, the studied market is anticipated to witness growth over the analysis period. However, the high cost of treatment and complicated reimbursement and regulatory policies are expected to restrain the market growth.
Soft Tissue Allografts Market Trends
Orthopedic Segment is Expected to Hold a Significant Market Share Over the Forecast Period
The orthopedics segment is likely to grow significantly during the forecast period. The high prevalence of orthopedic soft tissue damage is the major growth factor for the orthopedic segment. The tissues present primarily in the elbow, wrist, finger, thigh, and other body parts where tendons are present. This is the most common type of orthopedic soft tissue rupture that needs attention. Thus, such tissues require more orthopedic surgical treatments due to injuries. Therefore, such factors are expected to increase segment growth over the forecast period.
For instance, as per the 2021 update of the American Joint Replacement Registry (AJRR), around 105,743 hip arthroplasty procedures for femoral neck fractures were performed in 2020 in the United States. The increasing numbers of orthopedic procedures primarily contribute to soft tissue allograft procedures, which is expected to drive segment growth during the forecast period.
Furthermore, the injuries caused by accidents affect the soft tissues in various parts of the body. Hence, the high burden of accident casualties drives the market to grow. For instance, according to the data published by the Government of the United Kingdom, in May 2022, it has been observed that about 27,300 seriously injured (KSI) casualties were reported in Great Britain in 2021. In addition, as per the 2022 data published by the Brake Organization, about 26,701 people (25,892 in Britain and 809 in Northern Ireland) were seriously injured in the United Kingdom in 2021. These factors are expected to propel the segment's growth during the forecast period.
Additionally, the completion of successful surgeries using orthopedic allografts by market players is expected to boost the segment's demand during the forecast period. For instance, in December 2022, Umbra Applied Technologies Group, Inc conducted successful surgeries using the Ossifix Orthopedics allograft bone pin system.
Therefore, owing to the aforesaid factors, the segment is expected to witness growth during the forecast period.
North America is Expected to Hold a Significant Market Share Over the Forecast Period
North America is expected to hold a significant market share owing to factors such as the high incidence of sports injuries, product launches, and approvals along with the high concentration of market players in the region.
According to the 2022 Annual Report published by the Arizona Department of Health Services, State Trauma Advisory Board in 2022, the top mechanisms of injury for trauma cases in Arizona, Unites States in 2021 were 30,788 falls, 12,247 motor vehicle traffic (MVT)-occupant, 3,942 struck by/against, 2,897 motor vehicle non-traffic, 2,198 cut/pierce, and 2,105 firearms. There were also 7,069 pediatric traumatic injuries in Arizona, United States in 2022, and the top mechanisms of traumatic injury for children ages 0-17 years included falls, MVT-occupant, motor vehicle non-traffic, and struck by/against.
Furthermore, the company activities such as conferences for creating awareness regarding available allograft products are expected to propel the market growth. For instance, in January 2021, ProChondrix CR allograft developed by AlloSource was featured in a presentation by Dr. David Argo at the British Patellofemoral Society Meeting. During the session, Dr. Argo highlighted his experience repairing osteochondral defects of the knee with AlloSource's allograft in Ohio. Therefore, such events are expected to propel the demand for allografts among orthopedic physicians, thereby propelling market growth during the forecast period.
Therefore, owing to the above-mentioned factors, the growth of the studied market is anticipated in the North America Region.
Soft Tissue Allografts Industry Overview
The soft tissue allografts market is moderately competitive, and many global players are present in the market. Some of the market players include Abbvie Inc. (Allergan), Conmed Corporation, BD (Becton Dickinson and Company), Smith & Nephew (Osiris Therapeutics Inc.), Integra LifeSciences Corporation, Stryker Corporation, Zimmer Biomet, and Arthrex Inc.
Soft Tissue Allografts Market Leaders
-
Stryker Corporation
-
CONMED Corporation
-
Integra LifeSciences Corporation
-
Smith & Nephew (Osiris Therapeutics Inc.)
-
BD (Becton Dickinson and Company)
*Disclaimer: Major Players sorted in no particular order
Soft Tissue Allografts Market News
- In August 2022, orthopedic surgeons at University National Hospital performed the first meniscal transplant and implanted donor cartilage into the patient's knee in Scotland.
- In July 2022, AlloSource added a quadricep tendon to its AlloConnex line of tendons, ligaments, and fascia. AlloSource's AlloConnex quadricep tendon is used for cruciate ligament procedures and is available with or without the bone block for various surgical techniques.
Soft Tissue Allografts Market Report - Table of Contents
1. INTRODUCTION
- 1.1 Study Assumptions and Market Definitions
- 1.2 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
- 4.1 Market Overview
-
4.2 Market Drivers
- 4.2.1 Growing Cases of Orthopedics and Dentistry Related with Aging
- 4.2.2 Increasing Demand for Soft Tissue Allografts in Athletics and Other Sports
- 4.2.3 Advancements in Soft Tissue Replacement
-
4.3 Market Restraints
- 4.3.1 High Cost of Treatment
- 4.3.2 Complicated Reimbursement and Regulatory Policies
-
4.4 Porter's Five Forces Analysis
- 4.4.1 Threat of New Entrants
- 4.4.2 Bargaining Power of Buyers/Consumers
- 4.4.3 Bargaining Power of Suppliers
- 4.4.4 Threat of Substitute Products
- 4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION (Market Size by Value - USD Million)
-
5.1 By Type
- 5.1.1 Cartilage Allograft
- 5.1.2 Tendon Allograft
- 5.1.3 Meniscus Allograft
- 5.1.4 Dental Allograft
- 5.1.5 Other Types
-
5.2 By Application
- 5.2.1 Orthopedic
- 5.2.2 Dentistry
- 5.2.3 Wound Care
- 5.2.4 Other Applications
-
5.3 By End User
- 5.3.1 Hospitals
- 5.3.2 Aesthetic Centres
- 5.3.3 Orthopedic Clinics
- 5.3.4 Dental Clinics
- 5.3.5 Other End Users
-
5.4 Geography
- 5.4.1 North America
- 5.4.1.1 United States
- 5.4.1.2 Canada
- 5.4.1.3 Mexico
- 5.4.2 Europe
- 5.4.2.1 Germany
- 5.4.2.2 United Kingdom
- 5.4.2.3 France
- 5.4.2.4 Italy
- 5.4.2.5 Spain
- 5.4.2.6 Rest of Europe
- 5.4.3 Asia-Pacific
- 5.4.3.1 China
- 5.4.3.2 Japan
- 5.4.3.3 India
- 5.4.3.4 Australia
- 5.4.3.5 South Korea
- 5.4.3.6 Rest of Asia-Pacific
- 5.4.4 Middle East and Africa
- 5.4.4.1 GCC
- 5.4.4.2 South Africa
- 5.4.4.3 Rest of Middle East and Africa
- 5.4.5 South America
- 5.4.5.1 Brazil
- 5.4.5.2 Argentina
- 5.4.5.3 Rest of South America
6. COMPETITIVE LANDSCAPE
-
6.1 Company Profiles
- 6.1.1 Abbvie Inc. (Allergan)
- 6.1.2 Conmed Corporation
- 6.1.3 Xtant Medical Holdings Inc.
- 6.1.4 Bone Bank Allografts
- 6.1.5 Smith & Nephew (Osiris Therapeutics Inc.)
- 6.1.6 BD (Becton Dickinson and Company)
- 6.1.7 Integra LifeSciences Corporation
- 6.1.8 Stryker Corporation
- 6.1.9 Zimmer Biomet
- 6.1.10 Arthrex Inc.
- 6.1.11 Medtronic Plc
- 6.1.12 Johnson & Johnson Inc.
- *List Not Exhaustive
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
Soft Tissue Allografts Industry Segmentation
As per the scope of the report, soft tissue allografts are the substitute tissues, having application in the reconstruction of deficient ligaments, spinal surgeries, torn menisci, and osteochondral defects during knee surgeries. The Soft Tissue Allografts Market is Segmented by Type (Cartilage Allograft, Tendon Allograft, Meniscus Allograft, Dental Allograft, and Other Types), Application (Orthopedic, Dentistry, Wound Care, and Other Applications), End User (Hospitals, Aesthetic Centres, Orthopedic Clinics, Dental Clinics, and Other End Users) and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The market report also covers the estimated market sizes and trends for 17 countries across major regions globally. The report offers the value (in USD million) for the above segments.
| By Type | Cartilage Allograft | |
| Tendon Allograft | ||
| Meniscus Allograft | ||
| Dental Allograft | ||
| Other Types | ||
| By Application | Orthopedic | |
| Dentistry | ||
| Wound Care | ||
| Other Applications | ||
| By End User | Hospitals | |
| Aesthetic Centres | ||
| Orthopedic Clinics | ||
| Dental Clinics | ||
| Other End Users | ||
| Geography | North America | United States |
| Canada | ||
| Mexico | ||
| Geography | Europe | Germany |
| United Kingdom | ||
| France | ||
| Italy | ||
| Spain | ||
| Rest of Europe | ||
| Geography | Asia-Pacific | China |
| Japan | ||
| India | ||
| Australia | ||
| South Korea | ||
| Rest of Asia-Pacific | ||
| Geography | Middle East and Africa | GCC |
| South Africa | ||
| Rest of Middle East and Africa | ||
| Geography | South America | Brazil |
| Argentina | ||
| Rest of South America |
Soft Tissue Allografts Market Research FAQs
How big is the Soft Tissue Allografts Market?
The Soft Tissue Allografts Market size is expected to reach USD 3.70 billion in 2024 and grow at a CAGR of 6.74% to reach USD 5.12 billion by 2029.
What is the current Soft Tissue Allografts Market size?
In 2024, the Soft Tissue Allografts Market size is expected to reach USD 3.70 billion.
Who are the key players in Soft Tissue Allografts Market?
Stryker Corporation, CONMED Corporation, Integra LifeSciences Corporation, Smith & Nephew (Osiris Therapeutics Inc.) and BD (Becton Dickinson and Company) are the major companies operating in the Soft Tissue Allografts Market.
Which is the fastest growing region in Soft Tissue Allografts Market?
Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029).
Which region has the biggest share in Soft Tissue Allografts Market?
In 2024, the North America accounts for the largest market share in Soft Tissue Allografts Market.
What years does this Soft Tissue Allografts Market cover, and what was the market size in 2023?
In 2023, the Soft Tissue Allografts Market size was estimated at USD 3.45 billion. The report covers the Soft Tissue Allografts Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Soft Tissue Allografts Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029.
Soft Tissue Allografts Industry Report
Statistics for the 2024 Soft Tissue Allografts market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Soft Tissue Allografts analysis includes a market forecast outlook to for 2024 to 2029 and historical overview. Get a sample of this industry analysis as a free report PDF download.
